| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 740 | Methotrexate | 0.0138010872611484 | 0.34300075 |
| NSC 756053 | Null | 0.0138010872611484 | 0.070277833 |
| NSC 762559 | Null | 0.0138010872611484 | -0.19439678 |
| NSC 763059 | Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride | 0.0138010872611484 | 0.27202555 |
| NSC 104942 | EUPAROTIN | 0.0138010872611486 | -0.05204468 |
| NSC 140701 | Sulfanilanilide, 4'-(9-acridinylamino)-, monohydrochloride | 0.0138010872611486 | 0.19006173 |
| NSC 176507 | Fastigilin C | 0.0138010872611486 | -0.039365265 |
| NSC 276371 | 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- | 0.0138010872611486 | -0.09465808 |
| NSC 30916 | MP 317 | 0.0138010872611486 | -0.031078771 |
| NSC 261045 | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-, hydrochloride | 0.0145418727063286 | 0.23126657 |